Back to mobile site

Altimmune (ALT) Announces $25M Direct Offering via Roth Capital

October 8, 2018 9:01 AM EDT Send to a Friend
Altimmune, Inc. (Nasdaq: ALT) has entered into a purchase agreement with several institutional investors for the purchase of common units ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login